TY  - GEN
AU  - Van Hecken,A
AU  - Schwartz,J I
AU  - Depré,M
AU  - De Lepeleire,I
AU  - Dallob,A
AU  - Tanaka,W
AU  - Wynants,K
AU  - Buntinx,A
AU  - Arnout,J
AU  - Wong,P H
AU  - Ebel,D L
AU  - Gertz,B J
AU  - De Schepper,P J
TI  - Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers
SN  - 0091-2700
PY  - 2001///0201
KW  - Adolescent
KW  - Adult
KW  - Bleeding Time
KW  - Cyclooxygenase 1
KW  - Cyclooxygenase 2
KW  - Cyclooxygenase 2 Inhibitors
KW  - Cyclooxygenase Inhibitors
KW  - adverse effects
KW  - Diclofenac
KW  - Dinoprostone
KW  - metabolism
KW  - Female
KW  - Humans
KW  - Ibuprofen
KW  - Isoenzymes
KW  - antagonists & inhibitors
KW  - Lactones
KW  - Lipopolysaccharides
KW  - pharmacology
KW  - Meloxicam
KW  - Membrane Proteins
KW  - Middle Aged
KW  - Naproxen
KW  - Platelet Aggregation
KW  - drug effects
KW  - Prostaglandin-Endoperoxide Synthases
KW  - Prostaglandins
KW  - urine
KW  - Sulfones
KW  - Thiazines
KW  - Thiazoles
KW  - Thromboxane B2
KW  - blood
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
ER  -